Skip to main content
. 2022 Dec 18;14(24):6239. doi: 10.3390/cancers14246239

Figure 2.

Figure 2

R/PFS (recurrence/progression-free survival) of EOCRC (early-onset colorectal cancer) and LOCRC (late onset colorectal cancer) patients according to the postoperative tumoral stage: (A) RFS of EOCRC (red line) and LOCRC (black line) patients diagnosed with tumoral stage I were compared with Kaplan–Meier analysis and log-rank (Mantel–Cox) test (HR = 2.68; 95% CI: 1.07–6.72; p = 0.035). (B) RFS of EOCRC (red line) and LOCRC (black line) patients diagnosed with tumoral stage II were compared with Kaplan–Meier analysis and log-rank (Mantel˜Cox) test (HR = 0.98; 95% CI: 0.53–1.83; p = 0.955). (C) RFS of EOCRC (red line) and LOCRC (black line) patients diagnosed with tumoral stage III were compared with Kaplan˜Meier analysis and log-rank (Mantel˜Cox) test (HR = 1.43; 95% CI: 0.92–2.20; p = 0.108). (D) R/PFS of EOCRC (red line) and LOCRC (black line) patients diagnosed with tumoral stage IV were compared with Kaplan–Meier analysis and log-rank (Mantel–Cox) test (HR = 1.25; 95% CI: 0.93–1.67; p = 0.103).